ProMIS Neurosciences (PMN) Stock Statistics & Valuation Metrics

ProMIS Neurosciences has a market cap or net worth of $22.82M. The enterprise value is -$49.95M.

ProMIS Neurosciences has 2,152,397 shares outstanding. The number of shares has decreased by -2.65% in one year.

ProMIS Neurosciences’s return on equity (ROE) is 31.56 and return on invested capital (ROIC) is 3267.20%.

The current PE Ratio of ProMIS Neurosciences is ―. ProMIS Neurosciences’s PEG ratio is 0.33.

In the last 12 months, ProMIS Neurosciences had revenue of 0.00 and earned -39.72M in profits. Earnings per share was -22.61.

In the last 12 months, operating cash flow was -35.47M and capital expenditures 0.00, giving a free cash flow of -35.47M billion.

ProMIS Neurosciences pays an annual dividend of ―, resulting in a dividend yield of ―

ProMIS Neurosciences upcoming earnings date is Aug 17, 2026, Before Open (Confirmed).

ProMIS Neurosciences as a current ratio of 0.88, with Debt / Equity ratio of 0.00%

In the past 12 months, ProMIS Neurosciences has paid 0.00 in taxes.

ProMIS Neurosciences EV to EBITDA ratio is -301.95, with an EV/FCF ratio of -0.43.

ProMIS Neurosciences has $63.85M in cash and marketable securities with $0.00 in debt, giving a net cash position of $63.85M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for ProMIS Neurosciences is $36.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy